Plain-English translation of NCT07011979 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at Seoul National University Hospital are studying people who are at high risk of developing inflammatory bowel disease (IBD) — including family members of IBD patients and people with certain immune system markers. By analyzing blood and stool samples, they hope to identify biological clues that might predict who will develop IBD in the future, so doctors can potentially intervene earlier.
Inflammatory bowel disease is a serious condition that affects the digestive system, but many people develop it without warning. This study aims to find early biological markers that could help doctors identify and possibly prevent the disease in people who are most vulnerable, before symptoms appear.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic to provide blood and stool samples, and possibly have a small tissue biopsy taken. Researchers will analyze these samples to look for genetic and biological patterns associated with IBD risk. The study team will monitor you for any side effects from blood sampling during clinic visits. The study is enrolling 500 people total and is currently recruiting participants.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
South Korea